Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents for the treatment of ovarian cancer.

Abstract: The present invention provides a sewage treatment biological agent and a preparation method and application thereof. The sewage treatment biological agent according to an embodiment of the present invention includes an induced nucleus. The induced nucleus has good bioaffinity. A microbial flora can be attached to the induced nucleus to achieve rapid growth. As the microbial flora gathers and grows on the induced nucleus, the granulation is gradually achieved by the sewage treatment biological agent to facilitate the sewage treatment. The microbial flora grows on the induced nucleus, and the growth process of microbial flora is a covering growth process which starts from the induced nucleus and gradually expands outward and centers on the induced nucleus. During the growth of microbial flora, extracellular polymers are secreted, which can further promote the granulation process by the sewage treatment biological agent.

Abstract: The present invention provides a sewage treatment biological agent and a preparation method and application thereof. The sewage treatment biological agent according to an embodiment of the present invention includes an induced nucleus. The induced nucleus has good bioaffinity. A microbial flora can be attached to the induced nucleus to achieve rapid growth. As the microbial flora gathers and grows on the induced nucleus, the granulation is gradually achieved by the sewage treatment biological agent to facilitate the sewage treatment. The microbial flora grows on the induced nucleus, and the growth process of microbial flora is a covering growth process which starts from the induced nucleus and gradually expands outward and centers on the induced nucleus. During the growth of microbial flora, extracellular polymers are secreted, which can further promote the granulation process by the sewage treatment biological agent.

Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents for the treatment of ovarian cancer.

Abstract: The present invention relates to microbial carriers for wastewater treatment, and in particular, relates to an organic composite powder carrier and its application for strengthening biological denitrification in municipal wastewater treatment. The organic composite powder carrier is compounded by a microbial carrier with a relatively large equivalent particle size and an organic alternative carbon source in the form of ultrafine powder. The composite powder carrier in the present invention includes a dedicated organic alternative carbon source, such as polyhydroxyalkanoates (PHA). The organic alternative carbon source can exclude the competitive relationship between microorganisms to ensure that denitrifying bacteria exclusively obtain electron donors required for denitrification.

Abstract: The invention relates to a new biological fluidized bed process with high concentration powder carriers used for the treatment of municipal wastewater, which is a fluidized bed system based on the principle of sewage biochemical treatment, by adding a compound powder carrier to the biochemical tank, and forming a high concentration mixture after mixing and microbial attachment; the sludge mixture after the reaction is concentrated and separated, and then enters the compound powder carrier cyclone separation and recovery system, which can separate most of the compound powder carrier from the discharged excess sludge, and then return to the biochemical tank for recycling. The highly integrated municipal wastewater treatment process proposed in the invention has high treatment efficiency, small occupation area, low operation energy consumption, and can realize the doubling of sewage treatment capacity and the improvement of effluent water quality without adding additional occupancy.

Abstract: A recovery system of composite powder carrier in HPB municipal wastewater treatment includes a biochemical tank and a concentration tank. The composite powder carrier is added to the biochemical tank for biochemically treating on the wastewater. The mixed liquid is then made to flow into the concentration tank. The supernatant obtained after filtration is then discharged. The concentrated sludge is returned to the biochemical tank, and the excess concentrated sludge is transported to a separator. The separator separates the substances with large specific gravity from those having smaller specific gravity, and the substances with large specific gravity are recycled to the biochemical tank for reuse. Matter having smaller specific gravity is discharged. The separator can be used to separate the composite powder carriers for recycling, which improves the utilization rate of the composite powder carriers and reduces the operation cost of the HPB technology for wastewater treatment.

Abstract: A recovery system of composite powder carrier in HPB municipal wastewater treatment includes a biochemical tank and a concentration tank. The composite powder carrier is added to the biochemical tank for biochemically treating on the wastewater. The mixed liquid is then made to flow into the concentration tank. The supernatant obtained after filtration is then discharged. The concentrated sludge is returned to the biochemical tank, and the excess concentrated sludge is transported to a separator. The separator separates the substances with large specific gravity from those having smaller specific gravity, and the substances with large specific gravity are recycled to the biochemical tank for reuse. Matter having smaller specific gravity is discharged. The separator can be used to separate the composite powder carriers for recycling, which improves the utilization rate of the composite powder carriers and reduces the operation cost of the HPB technology for wastewater treatment.

Abstract: The present invention relates to microbial carriers for wastewater treatment, and in particular, relates to an organic composite powder carrier and its application for strengthening biological denitrification in municipal wastewater treatment. The organic composite powder carrier is compounded by a microbial carrier with a relatively large equivalent particle size and an organic alternative carbon source in the form of ultrafine powder. The composite powder carrier in the present invention includes a dedicated organic alternative carbon source, such as polyhydroxyalkanoates (PHA). The organic alternative carbon source can exclude the competitive relationship between microorganisms to ensure that denitrifying bacteria exclusively obtain electron donors required for denitrification.

Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents for the treatment of ovarian cancer.

Abstract: The present invention relates in general to municipal wastewater treatment, and in particular, to a new biological fluidized bed process with high concentration powder carriers used for the treatment of municipal wastewater, wherein the process comprises: flowing the wastewater through a coarse screen and a lifting pump firstly, lifting to a fine screen and grit chamber, and then entering a HPB biochemical tank; dividing the HPB biochemical tank successively into an anaerobic zone, an anoxic zone, an aerobic zone and a concentrated separation zone along the flow direction of the wastewater, adding a compound powder carrier to the anaerobic zone, the anoxic zone and the aerobic zone respectively, and stirring and mixing into a mixture; flowing the mixture into the concentrated separation zone and concentrating and separating, returning the concentrate back to the anaerobic zone; discharging the supernatant from the concentrated separation zone and successively transporting through a high-efficient clarificatio

Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents for the treatment of ovarian cancer.

Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents for the treatment of ovarian cancer.

Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents for the treatment of ovarian cancer.

Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents for the treatment of ovarian cancer.